Immediate Impact
64 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
2024 Standout
Works of Laura Tang being referenced
Current and Investigational Agents Targeting the Phosphoinositide 3‐Kinase Pathway
2018
Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Laura Tang | 481 | 507 | 347 | 15 | 768 | |
| Ann Michelini | 708 | 493 | 384 | 15 | 983 | |
| Concetta Sciammarella | 392 | 277 | 160 | 24 | 681 | |
| J. Peter | 681 | 625 | 407 | 12 | 923 | |
| Jeroen de Filette | 530 | 248 | 129 | 15 | 696 | |
| Riley Fadden | 696 | 231 | 186 | 19 | 890 | |
| Christopher Russell | 418 | 347 | 219 | 28 | 709 | |
| Wafae Iraqi | 137 | 77 | 238 | 17 | 829 | |
| J A van Heerden | 583 | 382 | 128 | 15 | 892 | |
| D H Stephens | 517 | 265 | 98 | 15 | 833 | |
| K. H. Fu | 449 | 69 | 118 | 26 | 888 |
All Works
Login with ORCID to disown or claim papers
Loading papers...